Monopar Therapeutics
MNPR
#7100
Rank
A$0.78 B
Marketcap
A$117.19
Share price
3.69%
Change (1 day)
226.86%
Change (1 year)

Monopar Therapeutics (MNPR) - Total assets

Total assets on the balance sheet as of June 2025 : A$80.7 Million

According to Monopar Therapeutics's latest financial reports the company's total assets are A$80.7 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Monopar Therapeutics - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$96.93 M799.08%
2023-12-31A$10.78 M-44.53%
2022-12-31A$19.43 M-31.33%
2021-12-31A$28.3 M29.03%
2020-12-31A$21.93 M15.04%
2019-12-31A$19.07 M83.58%
2018-12-31A$10.38 M-18.34%
2017-12-31A$12.72 M216.68%
2016-12-31A$4.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ORIC Pharmaceuticals
ORIC
A$0.64 B 700.49%๐Ÿ‡บ๐Ÿ‡ธ USA